198,60 €
0,68 % heute
L&S, 4. Februar, 22:55 Uhr
ISIN
US4781601046
Symbol
JNJ
Berichte

Johnson & Johnson Aktie News

Positiv
Market Watch
etwa 4 Stunden alt
The industrials sector has been a big beneficiary of the rotation out of tech, with a number of defense and transportation stocks hitting new highs on Wednesday.
Positiv
The Motley Fool
etwa 6 Stunden alt
Johnson & Johnson's growth rate improved this past year, and that trend is likely to continue. The company sees a lot of growth ahead, particularly in its oncology business.
Positiv
Forbes
ein Tag alt
In the nearly nine months spanning from May 2025 to February 2026, Johnson & Johnson (JNJ)'s stock experienced a remarkable 52% increase, driven by improved earnings, significant product achievements, and advancements in legal matters. Behind this 3.2% uplift in revenue and enhancement in margins is a narrative of innovation, effective risk management, and strategic evolution—let's delve into w...
Neutral
GlobeNewsWire
ein Tag alt
World's #1 Selling Contact Lens Brand ACUVUE®*1 Brings Pioneering Innovation For Astigmatic Patients With Presbyopia, Providing Visual Clarity And Comfort**2
Neutral
Business Wire
2 Tage alt
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3rd, 2026. Management will participate in a Fireside Chat at 11:10 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition o...
Positiv
Seeking Alpha
3 Tage alt
Barrick Mining Corporation's solid liquidity supports its commitment to shareholder returns, reflected in increased share repurchases and a raise in its quarterly dividend. Johnson & Johnson's performance was augmented by key growth products like Carvykti, promising new data for Rybrevant and more favorable erosion trends for legacy franchises. Fiserv's scale, integrated solutions and deep clie...
Positiv
The Motley Fool
4 Tage alt
These companies have a long history of dividend growth, spanning more than 50 years. Passive income is something that rewards investors in any market environment.
Positiv
The Motley Fool
5 Tage alt
Johnson & Johnson could become the second biopharma company to achieve $100 billion in annual sales. The healthcare leader has a robust and diversified business that can support its dividend program.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen